Cofactor Genomics today announced publication of its OncoPrism®-NSCLC clinical validation study in npj Precision Oncology, a peer-reviewed Nature Portfolio journal. The study represents the latest ...
A new open-source Python package called ROOFS benchmarks multiple feature selection methods on a researcher's own data, ...
Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...
A new review argues that the slow clinical translation of RNA 5-methylcytosine cancer biomarkers stems from a lack of ...
A multimodal artificial intelligence (MMAI)–derived predictive biomarker was trained for long-term (LT) versus short-term (ST) ADT using pretreatment digital prostate biopsy images and clinical data ...
Boost ROI through pharma-diagnostic collaborations, AI-driven analytics, multi-omics investment, and co-developed companion diagnostics and targeted therapies.Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE) -- ...
Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...
Background: The Prognostic Lung Fibrosis Consortium (PROLIFIC) was formed to develop well-qualified assays suitable for use as prognostic biomarkers within the context of clinical trials for Idiopathic ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
Analyzing thousands of proteins from a single drop of blood is no longer science fiction. High-throughput proteomics has transformed biomarker discovery by enabling simultaneous profiling of thousands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results